Background and Philosophy

Trial Runners, LLC was launched in 2006 by founders Patrick Healy and Jill Healy. Together they bring over 25 years of clinical research management experience from within pharmaceutical companies. Knowing the challenges biotech and pharmaceutical companies face, they saw an opportunity to improve upon the clinical Contract Research Organization (CRO) Industry.

Their background and insight inspired them to enhance clinical research management through innovative solutions. Out of experience grew a philosophy focused on responsiveness, execution, expert project management, lower costs and valued relationships. Providing you with experienced clinical professionals means accurate, timely research aligned with your budget.

Headquarters for Trial Runners is located in North Dakota.  Jill Healy was born and raised in North Dakota and after making many trips  from New York City with Patrick to North Dakota to visit family, the founders fell in love with the state and realized the incredible opportunity that existed to launch a top tier global CRO in the state.  The founders decided to move from New York City to North Dakota to launch Trial Runners. Besides family and quality of life reasons, then why, you ask? Cost of doing business. North Dakota is ranked 6th in the nation according to CNBC’s 2009 lowest cost of doing business. Combine that with a ranking of 11th with access to capital, the decision was an easy one. Many of our core employees still work in NYC and Los Angeles. Having the HQ in ND allows us to benefit from state grants, interest buy downs and reimbursement for training and development. We weren’t afraid to think outside the box in order to launch the company in the most successful way. The truth is, it really doesn’t matter where a CRO is located anymore. We feel that our responsiveness to clients is unmatched in the industry and that is what matters most.

Why use Trial Runners?

Prior to joining Trial Runners, The core personnel has had extensive experience with CROs  while working within pharmaceutical and biotech companies, so we know exactly what our clients want from us. 

Our biggest differentiator is our PEOPLE:iStock_000009903134XSmall

  • On the Cutting Edge- We value our staff and provide up to date training to ensure expertise, strategic planning, and execution on each project

  • “All Hands on Deck Approach” - different allocations are needed at different times for a project. Our staff is available to handle any ad hoc requests (e.g. data review, data locking, extra monitoring visits) and changing objectives quickly and efficiently.

  • Commitment- when you hire Trial Runners, you hire the entire company. Our turnover rate is extremely low compared to other CROs.

  • Thinking like a Pharmaceutical Company - from its inception, each project and budget is specifically developed for our clients.

  • Pricing - our confidence lies in understanding the needs of each of our clients. We commit to our budgets and never submit out of scope payment requests, unless the sample size changes or additional countries are added. Guaranteed.

  • Active Communication – the success of a project lies in the ability to communicate. The executive team is available 24 hours a day at no extra cost to speak with clients should they have any concerns. We encourage our clients to communicate any issues with us immediately.

  • Trustworthy – Our clients repeatedly tell us how much they trust us. One client even told us, “The difference with you guys is that you actually care.” We receive this kind of feedback because we knew what would make a great CRO when we launched Trial Runners. We knew from our own experience that pharmaceutical and biotech companies need a CRO who is extremely responsive, trustworthy and can execute a program with a set budget.

    •   

    WE ARE A FULL-SERVICE CRO ENHANCED BY THE PEOPLE THAT WORK THERE

     

    Since our launch in June 2006, we have worked with over 2100 patients globally.  We are currently working on 11 clinical studies : 6 phase I, 1 phase II, 1 phase III, 1 phase IV and 2 marketing device studies.

  • Therapeutic areas (with drugs and devices): Ophthalmology, renal failure, hepatic failure (in a pediatric population), pharmacokinetics, biomarker studies, diagnostic software/technology, pharmacoeconomics and medical devices; Anti-infectives;
  • Therapeutic experience from the individuals within the company include (but not limited to):  Ophthalmology, oncology, Women's Health, dermatology, neurology, cardiovascular, gastroenterology, HIV, anti-fungal,  diabetes and hepatitis
  • Specific ophthalmology experience: Wet and dry AMD, glaucoma, uveitis, retinal vein occlusion, dry eye syndrome, diabetic retinopathy and corneal allograft failure.
  • We have worked with 13 biotech/pharmaceutical clients in various stages of development
  • The Executive Team also provides strategic consulting throughout the pre-IND process which has been especially helpful to biotech companies lacking significant clinical development experience.

    •  

    Overall Capabilities

  • Our professionals are strategically located across the globe.
  • Clinical Staff includes regional monitors, project managers, data managers, statisticians, medical/pharmacovigilance personnel, medical writers, and CRAs.
  • Trial Runners provides continuous training and development of all staff
  • Outstanding project managerswho are trained in biotech and pharmaceutical companies and have the t capability topartner with clinical and commercial teams
  • Proposals from Trial Runners are guaranteed to come in at rates significantly less than every large CRO

    •  

     

    "Trial Runners has extensive experience in ophthalmic drug development and is run by the most capable and trustworthy people I know. I look forward to working with them again in the future."- Anthony P. Adamis, MD, Global Head of Ophthalmology, Genentech